This inventor holds 8 USPTO granted patents and 5 published patent applications. Top assignee: Enveric Biosciences Canada Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Glynnis Elizabeth Jensen: Innovator in Fused Heterocyclic Mescaline Derivatives
Introduction
Glynnis Elizabeth Jensen is a prominent inventor based in Calgary, Canada. She has made significant contributions to the field of pharmaceutical and recreational drug formulations, holding a total of seven patents. Her innovative work focuses on novel fused heterocyclic mescaline derivative compounds.
Latest Patents
Among her latest patents are the "Fused Heterocyclic Mescaline Derivatives," which disclose novel compounds and methods for creating and utilizing these derivatives. Another notable patent is the "Substituted N-Propylamine Fused Heterocyclic Mescaline Derivatives," which includes various formulations and methods related to these compounds. Both patents highlight her expertise in developing new drug formulations.
Career Highlights
Glynnis has established herself as a key figure in her field through her innovative research and development efforts. Her work at Enveric Biosciences Canada Inc. has allowed her to explore the potential applications of her inventions in the pharmaceutical industry.
Collaborations
Glynnis collaborates with talented individuals such as Kaveh Matinkhoo and David James Press, contributing to a dynamic research environment that fosters innovation.
Conclusion
Glynnis Elizabeth Jensen's contributions to the field of fused heterocyclic mescaline derivatives exemplify her dedication to innovation and research. Her work continues to influence the development of new pharmaceutical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile